News
Re-rostered FDA committee backs peptide compounding
Against the advice of FDA staff scientists, an advisory committee has narrowly voted in support of looser restrictions on compounded peptides.
News
EU clears AZ's SERD camizestrant, as FDA review drags on
AstraZeneca's new breast cancer therapy Etcamah claims landmark frontline approval in the EU, but its prospects in the US are less certain.
News
Nuvalent buy delivers new cancer approval for GSK
GSK has its first approval from the $10.6bn takeover of Nuvalent, ROS1+ NSCLC therapy Jideytro, which becomes the company's first lung cancer product.
News
As patents expire, fampridine is cleared for NHS use in MS
Several years after other UK nations, people living with multiple sclerosis in England are finally able to get NHS treatment with fampridine.
News
Takeda gets first OK for orexin narcolepsy drug, in China
China has become the first country to approve Takeda's first-in-class orexin agonist, oveporexton, for the sleep disorder narcolepsy.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
